ResistancePlus MG* is a multiplex qPCR test for detection of Mycoplasma genitalium and five macrolide resistance markers from male and female urine and swab specimens. Proprietary PlexZyme® and PlexPrime® technologies improve multiplex performance compared with other probe-based tests allowing for multiple mutation detection in a single well.
|Performance of ResistancePlus® MG|
|MG detection||Resistance markers|
*not for sale in USA
What is Mycoplasma genitalium?
Mycoplasma genitalium (M. genitalium) is a sexually transmitted infection (STI) that can cause symptoms including urethritis, cervicitis, endometritis and pelvic inflammatory disease1. In the general population, the prevalence of M. genitalium ranges from 1% – 3%2 and in higher risk populations it ranges from 10 – 50%1, often exceeding that of Neisseria gonorrhoeae infection.1 Mycoplasma genitalium infection has been largely under reported due to the difficulty of isolating and culturing the organism. This difficulty means that molecular (NAAT) testing is the only practical method to reliably identify the bacteria.
Journal of Infectious Diseases – Mycoplasma genitalium from Basic Science to Public Health Implications: The Results of an NIAID Technical Consultation
Screening for M. genitalium: Criteria for instituting a screening program and addressing the need for M. genitalium screening.
Read the full article | Digital PDF
MLO May Edition – MG: The New STI Superbug?
Clinical and diagnostic challenges of antimicrobial resistance in Mycoplasma genitalium.
MLO Digital PDF
Clinical Lab Products – Health: For drug resistant STIs, detection is not enough
Learn how SpeeDx technology is providing the right tools to manage antimicrobial resistant M. genitalium to help support antibiotic stewardship.
Read the full article | PDF Download
Media Planet – Antibiotic Resistance: New diagnostics change the way STI’s are treated
Antibiotic Resistance Diagnostic advancements have provided invaluable insight to help tackle the growing problem of antimicrobial resistance.